These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21398617)

  • 1. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
    Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P
    J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 production by B cells expressing CD5 with the alternative exon 1B.
    Garaud S; Le Dantec C; de Mendoza AR; Mageed RA; Youinou P; Renaudineau Y
    Ann N Y Acad Sci; 2009 Sep; 1173():280-5. PubMed ID: 19758163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of interleukin 10 in B lymphocytes of different origin.
    Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
    Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
    Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
    J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
    Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
    Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
    Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
    Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6, IL-10, c-Jun and STAT3 expression in B-CLL.
    Antosz H; Wojciechowska K; Sajewicz J; Choroszyńska D; Marzec-Kotarska B; Osiak M; Pająk N; Tomczak W; Jargiełło-Baszak M; Baszak J
    Blood Cells Mol Dis; 2015 Mar; 54(3):258-65. PubMed ID: 25477266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
    Defrance T; Vanbervliet B; Durand I; Banchereau J
    Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute alcohol activates STAT3, AP-1, and Sp-1 transcription factors via the family of Src kinases to promote IL-10 production in human monocytes.
    Norkina O; Dolganiuc A; Shapiro T; Kodys K; Mandrekar P; Szabo G
    J Leukoc Biol; 2007 Sep; 82(3):752-62. PubMed ID: 17575268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of signal transducer and activation of transcription (STAT)6 and STAT3 expression in stimulated B and T cells.
    Arinobu Y; Sugimoto R; Akaiwa M; Arima K; Otsuka T; Hamasaki N; Izuhara K
    Biochem Biophys Res Commun; 2000 Oct; 277(2):317-24. PubMed ID: 11032724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes.
    Schena M; Gaidano G; Gottardi D; Malavasi F; Larsson LG; Nilsson K; Caligaris-Cappio F
    Leukemia; 1992 Feb; 6(2):120-5. PubMed ID: 1372670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.
    Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
    Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
    Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
    J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference of IL-10 in leukemic B-1 cells.
    McCarthy BA; Mansour A; Lin YC; Kotenko S; Raveche E
    Cancer Immun; 2004 Jul; 4():6. PubMed ID: 15270555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia.
    Sainz-Perez A; Gary-Gouy H; Portier A; Davi F; Merle-Beral H; Galanaud P; Dalloul A
    Leukemia; 2006 Mar; 20(3):498-504. PubMed ID: 16408101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells.
    Zheng Z; Venkatapathy S; Rao G; Harrington CA
    Leukemia; 2002 Dec; 16(12):2429-37. PubMed ID: 12454749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.